Infections in Transplant Patients

Medical Clinics of North America

Volumn 97, Issue 4, 2013, Pages 581-600

  Pagalilauan, Genevieve L ^a   Limaye, Ajit P ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Common infections; Opportunistic infections; Primary care; Solid organ transplant

Indexed keywords

AMANTADINE; AMLODIPINE; COTRIMOXAZOLE; CYCLOSPORIN; IMIPENEM; INFLUENZA VACCINE; LINEZOLID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSELTAMIVIR; PERTUSSIS VACCINE; PREDNISONE; SULFAMETHOXAZOLE; TACROLIMUS; WART VIRUS VACCINE; ZANAMIVIR;

ACUTE PYELONEPHRITIS; ALLERGY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; AUTOIMMUNE HEPATITIS; BACTERIAL SUPERINFECTION; BLADDER CATHETERIZATION; BLASTOMYCES; BLOOD CELL COUNT; BLOOD CULTURE; CANCER SCREENING; CELLULAR IMMUNITY; CERVICAL LYMPHADENOPATHY; CHRONIC DISEASE; CHRONIC HEPATITIS; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COCCIDIOIDES; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONGESTIVE HEART FAILURE; COUGHING; CRYPTOCOCCUS; CYTOMEGALOVIRUS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIPHTHERIA; DYSPNEA; EPSTEIN BARR VIRUS; ERYTHEMA; ESCHERICHIA COLI; FATIGUE; FEVER; FOLLOW UP; FOOD INTAKE; GOLD STANDARD; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HAEMOPHILUS INFLUENZAE; HEADACHE; HEALTH CARE PLANNING; HEART GRAFT; HEMATOPOIETIC CELL; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX VIRUS; HISTOPLASMA; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HUMORAL IMMUNITY; HYPERLIPIDEMIA; HYPERTENSION; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTIOUS COMPLICATION; INFLUENZA A; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INVASIVE PROCEDURE; KIDNEY GRAFT; KLEBSIELLA PNEUMONIAE; LEGIONELLA PNEUMOPHILA; LIVER GRAFT; LOWER RESPIRATORY TRACT INFECTION; LUNG TRANSPLANTATION; MULTICENTER STUDY (TOPIC); MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NOSE SECRETION; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; OSTEOPOROSIS; PERCUSSION; PERTUSSIS; PNEUMOCOCCAL INFECTION; PNEUMOCYSTIS; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PREGNANCY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; REVIEW; RHINORRHEA; RISK FACTOR; SEROLOGY; SEXUAL BEHAVIOR; SOLID ORGAN TRANSPLANT; SORE THROAT; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STRONGYLOIDES STERCORALIS; TETANUS; THORAX RADIOGRAPHY; TOOTH DISEASE; TREATMENT DURATION; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; UTERINE CERVIX CANCER; VANCOMYCIN RESISTANT ENTEROCOCCUS; VESICOURETERAL REFLUX; WART VIRUS; WHEEZING;

HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 84879714967     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2013.03.002     Document Type: Review

References (45)

1. Lodhi S.A., Lamb K.E., Meier-Kriesche H.U. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant 2011, 11(6):1226-1235. 10.1111/j.1600-6143.2011.03539.x.
2. GKT1 activities and practices. World Health Organization Web site. Available at: Accessed November 14, 2012. http://www.who.int/transplantation/gkt/statistics/en/.
3. Wolfe R.A., Roys E.C., Merion R.M. Trends in organ donation and transplantation inthe United States, 1999-2008. Am J Transplant 2010, 10(4 Pt 2):961-972. 10.1111/j.1600-6143.2010.03021.x.
4. Cervera C., Fernandez-Ruiz M., Valledor A., et al. Epidemiology and risk factors for late infection in solid organ transplant recipients. Transpl Infect Dis 2011, 13(6):598-607. 10.1111/j.1399-3062.2011.00646.x.
5. Fishman J.A. Infection in solid-organ transplant recipients. NEngl J Med 2007, 357(25):2601-2614. 10.1056/NEJMra064928.
6. Kale M.S., Bishop T.F., Federman A.D., et al. Trends in the overuse of ambulatory health care services in the United States. Arch Intern Med 2012, 1-7. 10.1001/2013.jamainternmed.1022.
7. Fishman J.A. Infections in immunocompromised hosts and organ transplant recipients: essentials. Liver Transpl 2011, 17(Suppl 3):S34-S37. 10.1002/lt.22378.
8. Kumar D., Humar A., Plevneshi A., et al. Invasive pneumococcal disease in solid organ transplant recipients-10-year prospective population surveillance. Am J Transplant 2007, 7(5):1209-1214. 10.1111/j.1600-6143.2006.01705.x.
9. Fishman J.A., Greenwald M.A., Grossi P.A. Transmission of infection with human allografts: essential considerations in donor screening. Clin Infect Dis 2012, 55(5):720-727. 10.1093/cid/cis519.
10. Hoyo I., Sanclemente G., Cervera C., et al. Opportunistic pulmonary infectionsinsolid organ transplant recipients. Transplant Proc 2012, 44(9):2673-2675. 10.1016/j.transproceed.2012.09.067.
11. Harper S.A., Bradley J.S., Englund J.A., et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009, 48(8):1003-1032. 10.1086/598513.
12. Weigt S.S., Gregson A.L., Deng J.C., et al. Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients. Semin Respir Crit Care Med 2011, 32(4):471-493. 10.1055/s-0031-1283286.
13. Gainer S.M., Patel S.J., Seethamraju H., et al. Increased mortality of solid organ transplant recipients with H1N1 infection: a single center experience. Clin Transplant 2012, 26(2):229-237. 10.1111/j.1399-0012.2011.01443.x.
14. Martin S.T., Torabi M.J., Gabardi S. Influenza in solid organ transplant recipients. Ann Pharmacother 2012, 46(2):255-264. 10.1345/aph.1Q436.
15. Perez-Romero P., Aydillo T.A., Perez-Ordonez A., et al. Reduced incidence of pneumonia in influenza-vaccinated solid organ transplant recipients with influenza disease. Clin Microbiol Infect 2012, 18(12):E533-E540. 10.1111/1469-0691.12044.
16. Avery R.K. Influenza vaccines in the setting of solid-organ transplantation: are they safe?. Curr Opin Infect Dis 2012, 25(4):464-468. 10.1097/QCO.0b013e328355a79b.
17. Sousa D., Justo I., Dominguez A., et al. Community-acquired pneumonia in immunocompromised older patients: incidence, causative organisms and outcome. Clin Microbiol Infect 2012, 10.1111/j.1469-0691.2012.03765.x.
18. Cervera C., Agusti C., Angeles Marcos M., et al. Microbiologic features and outcome of pneumonia in transplanted patients. Diagn Microbiol Infect Dis 2006, 55(1):47-54. 10.1016/j.diagmicrobio.2005.10.014.
19. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl 2):S27-S72. 10.1086/511159.
20. Ramirez P., Valencia M., Torres A. Bronchoalveolar lavage to diagnose respiratory infections. Semin Respir Crit Care Med 2007, 28(5):525-533. 10.1055/s-2007-991524.
21. Waite S., Jeudy J., White C.S. Acute lung infections in normal and immunocompromised hosts. Radiol Clin North Am 2006, 44(2):295-315. ix. 10.1016/j.rcl.2005.10.009.
22. Georghiou P.R., Blacklock Z.M. Infection with Nocardia species in Queensland. A review of 102 clinical isolates. Med J Aust 1992, 156(10):692-697.
23. Tan C.K., Lai C.C., Lin S.H., et al. Clinical and microbiological characteristics of nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998-2008. Clin Microbiol Infect 2010, 16(7):966-972. 10.1111/j.1469-0691.2009.02950.x.
24. Krones E., Hogenauer C. Diarrhea in the immunocompromised patient. Gastroenterol Clin North Am 2012, 41(3):677-701. 10.1016/j.gtc.2012.06.009.
25. Rice J.P., Spier B.J., Cornett D.D., et al. Utility of colonoscopy in the evaluation of diarrhea in solid organ transplant recipients. Transplantation 2009, 88(3):374-379. 10.1097/TP.0b013e3181ae98ab.
26. Boutros M., Al-Shaibi M., Chan G., et al. Clostridium difficile colitis: increasing incidence, risk factors, and outcomes in solid organ transplant recipients. Transplantation 2012, 93(10):1051-1057. 10.1097/TP.0b013e31824d34de.
27. Yoder J.S., Wallace R.M., Collier S.A., et al. Centers for Disease Control and Prevention (CDC). Cryptosporidiosis surveillance-United States, 2009-2010. MMWR Surveill Summ 2012, 61(5):1-12.
28. Bonatti H., Barroso Ii L.F., Sawyer R.G., et al. Cryptosporidium enteritis in solid organ transplant recipients: multicenter retrospective evaluation of 10 cases reveals an association with elevated tacrolimus concentrations. Transpl Infect Dis 2012, 14(6):635-648. 10.1111/j.1399-3062.2012.00719.x.
29. Vidal E., Torre-Cisneros J., Blanes M., et al. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort. Transpl Infect Dis 2012, 14(6):595-603. 10.1111/j.1399-3062.2012.00744.x.
30. Saemann M., Horl W.H. Urinary tract infection in renal transplant recipients. EurJClin Invest 2008, 38(Suppl 2):58-65. 10.1111/j.1365-2362.2008.02014.x.
31. Silva A., Rodig N., Passerotti C.P., et al. Risk factors for urinary tract infection afterrenal transplantation and its impact on graft function in children and youngadults. JUrol 2010, 184(4):1462-1467. 10.1016/j.juro.2010.06.028.
32. Iqbal T., Naqvi R., Akhter S.F. Frequency of urinary tract infection in renal transplant recipients and effect on graft function. JPak Med Assoc 2010, 60(10):826-829.
33. Rice J.C., Safdar N., AST Infectious Diseases Community of Practice Urinary tract infections in solid organ transplant recipients. Am J Transplant 2009, 9(Suppl 4):S267-S272. 10.1111/j.1600-6143.2009.02919.x.
34. Neuner E.A., Sekeres J., Hall G.S., et al. Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms. Antimicrob Agents Chemother 2012, 56(11):5744-5748. 10.1128/AAC.00402-12.
35. Masters J.M., Thomsen A.K., Hayney M.S. Vaccinations in solid-organ transplant patients: what a health professional should know. JAm Pharm Assoc (2003) 2009, 49(3):458-459. 10.1331/JAPhA.2009.09508.
36. Danzinger-Isakov L., Kumar D., AST Infectious Diseases Community of Practice Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2009, 9(Suppl 4):S258-S262. 10.1111/j.1600-6143.2009.02917.x.
37. Agarwal N., Ollington K., Kaneshiro M., et al. Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review. Vaccine 2012, 30(8):1413-1424. 10.1016/j.vaccine.2011.11.109.
38. Kumar D., Rotstein C., Miyata G., et al. Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients. JInfect Dis 2003, 187(10):1639-1645. 10.1086/374784.
39. Centers for Disease Control and Prevention (CDC) Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2012, 61(40):816-819.
40. Avery R.K., Michaels M. Update on immunizations in solid organ transplant recipients: what clinicians need to know. Am J Transplant 2008, 8(1):9-14. 10.1111/j.1600-6143.2007.02051.x.
41. Veroux M., Corona D., Scalia G., et al. Surveillance of human papilloma virus infection and cervical cancer in kidney transplant recipients: preliminary data. Transplant Proc 2009, 41(4):1191-1194. 10.1016/j.transproceed.2009.03.015.
42. Wong G., Chapman J.R., Craig J.C. Cancer screening in renal transplant recipients: what is the evidence?. Clin J Am Soc Nephrol 2008, 3(Suppl 2):S87-S100. 10.2215/CJN.03320807.
43. Moyer V.A., U.S.Preventive Services Task Force Screening for cervical cancer:U.S. preventive services task force recommendation statement. Ann Intern Med 2012, 156(12):880-891. W312. 10.7326/0003-4819-156-12-201206190-00424.
44. Engels E.A., Pfeiffer R.M., Fraumeni J.F., et al. Spectrum of cancer risk among USsolid organ transplant recipients. JAMA 2011, 306(17):1891-1901. 10.1001/jama.2011.1592.
45. Origoni M., Stefani C., Dell'Antonio G., et al. Cervical human papillomavirus in transplanted Italian women: a long-term prospective follow-up study. JClin Virol 2011, 51(4):250-254. 10.1016/j.jcv.2011.05.017.